Common use of INDEMNIFICATION BY ICN Clause in Contracts

INDEMNIFICATION BY ICN. Subject to Section 6.3, ICN shall indemnify, defend, and hold harmless Ribapharm, all Ribapharm Affiliates, and each of their respective directors, officers and employees (in their capacities as such), from and against: (a) all Losses relating to, arising out of, or due to, directly or indirectly, any breach by ICN or any ICN Affiliate of any of the provisions of this Agreement; (b) all Losses relating to, arising out of, or due to, directly or indirectly, any incorrect, inaccurate or incomplete financial and other information provided by ICN or any ICN Affiliate to Ribapharm pursuant to Section 5.1 of this Agreement; (c) all Losses relating to, arising out of, or due to, directly or indirectly, any expenses, monetary judgment or settlement incurred in connection with the pending civil lawsuit by the SEC against ICN and related parties in the United States District Court for the Central District of California, the plea settling the US Attorney's Office investigation in the United States District Court for the Central District of California or the litigation involving the Republic of Serbia, the Federal Republic of Yugoslavia and the State Health Fund of Serbia relating to ICN's interest in ICN Yugoslavia; and (d) all Losses that result from any Third-Party Claim arising out of the business or operation of the ICN Business.

INDEMNIFICATION BY ICN. Subject to Section 6.3, ICN shall indemnify, defend, and hold harmless Ribapharm, all Ribapharm Affiliates, and each of their respective directors, officers and employees (in their capacities as such), from and against: (a) all Losses relating to, arising out of, or due to, directly or indirectly, any breach by ICN or any ICN Affiliate of any of the provisions of this Agreement; (b) all Losses relating to, arising out of, or due to, directly or indirectly, any incorrect, inaccurate or incomplete financial and other information provided by ICN or any ICN Affiliate to Ribapharm pursuant to Section 5.1 of this Agreement; (c) all Losses relating to, arising out of, or due to, directly or indirectly, any expenses, monetary judgment or settlement incurred in connection with the pending civil lawsuit by the SEC against ICN and related parties in the United States District Court for the Central District of California, the plea settling current criminal investigation of ICN and related parties by a Grand Jury (in conjunction with the US U.S. Attorney's Office investigation Office) in the United States District Court for the Central District of California or the litigation involving the Republic of Serbia, the Federal Republic of Yugoslavia and the State Health Fund of Serbia relating to ICN's interest in ICN Yugoslavia; and (d) all Losses that result from any Third-Party Claim arising out of the business or operation of the ICN Business.